EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Enoxacin adversely affects Salmonella enterica virulence and host pathogenesis through interference with type III secretion system type II (T3SS-II) and disruption of translocation of Salmonella Pathogenicity Island-2 (SPI2) effectors

El-Sayed Khafagy, Gamal A Soliman, Maged S Abdel-Kader, Mahmoud M Bendary, Wael A H Hegazy, Momen Askoura

Journal of Microbiology · 2025

DOI: 10.71150/jm.2410015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Microbiology, 2025. Verfasst von El-Sayed Khafagy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj 11942, Saudi Arabia. Hauptthemen laut MEDLINE: Type III Secretion Systems, Bacterial Proteins, Enoxacin, Anti-Bacterial Agents. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Prince Sattam bin Abdulaziz University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Salmonella enterica is a clinically significant oro-fecal pathogen that causes a wide variety of illnesses and can lead to epidemics. S. enterica expresses a lot of virulence factors that enhance its pathogenesis in host. For instance, S. enterica employs a type three secretion system (T3SS) to translocate a wide array of effector proteins that could change the surrounding niche ensuring suitable conditions for the thrive of Salmonella infection. Many antimicrobials have been recently introduced to overcome the annoying bacterial resistance to antibiotics. Enoxacin is member of the second-generation quinolones that possesses a considerable activity against S. enterica. The present study aimed to evaluate the effect of enoxacin at sub-minimum inhibitory concentration (sub-MIC) on S. enterica virulence capability and pathogenesis in host. Enoxacin at sub-MIC significantly diminished both Salmonella invasion and intracellular replication within the host cells. The observed inhibitory effect of enoxacin on S. enterica internalization could be attributed to its ability to interfere with translocation of the T3SS effector proteins. These results were further confirmed by the finding that enoxacin at sub-MIC down-regulated the expression of the genes encoding for T3SS-type II (T3SS-II). Moreover, enoxacin at sub-MIC lessened bacterial adhesion to abiotic surface and biofilm formation which indicates a potential anti-virulence activity. Importantly, in vivo results showed a significant ability of enoxacin to protect mice against S. enterica infection and decreased bacterial colonization within animal tissues. In nutshell, current findings shed light on an additional mechanism of enoxacin at sub-MIC by interfering with Salmonella intracellular replication. The outcomes presented herein could be further invested in conquering bacterial resistance and open the door for additional effective clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Type III Secretion SystemsBacterial ProteinsEnoxacinAnti-Bacterial AgentsSalmonella entericaMembrane ProteinsSalmonella typhimuriumAnimalsVirulenceMiceHumansMicrobial Sensitivity TestsSalmonella InfectionsVirulence FactorsMice, Inbred BALB CGenomic IslandsGene Expression Regulation, BacterialFemale

Stichwörter der Autor:innen

Salmonellaanti-virulenceenoxacintype three secretion system

Substanzen

Type III Secretion SystemsBacterial ProteinsEnoxacinAnti-Bacterial AgentsSPI-2 protein, SalmonellaVirulence FactorsMembrane Proteins

Autor:innen und Institutionen

  • Department of Pharmaceutics, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj 11942, Saudi Arabia.
  • Department of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
  • Department of Pharmacology, College of Veterinary Medicine, Cairo University, Giza 12211, Egypt.
  • Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
  • Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Alexandria 21215, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Port Said University, Port Said 42511, Egypt.

Förderung

  • Prince Sattam bin Abdulaziz University

Zitieren

APA

Khafagy, E. S., Soliman, G. A., Abdel-Kader, M. S., Bendary, M. M., Hegazy, W. A. H., & Askoura, M. (2025). Enoxacin adversely affects Salmonella enterica virulence and host pathogenesis through interference with type III secretion system type II (T3SS-II) and disruption of translocation of Salmonella Pathogenicity Island-2 (SPI2) effectors. Journal of Microbiology. https://doi.org/10.71150/jm.2410015

Vancouver

Khafagy ES, Soliman GA, Abdel-Kader MS, Bendary MM, Hegazy WAH, Askoura M. Enoxacin adversely affects Salmonella enterica virulence and host pathogenesis through interference with type III secretion system type II (T3SS-II) and disruption of translocation of Salmonella Pathogenicity Island-2 (SPI2) effectors. Journal of Microbiology. 2025. doi:10.71150/jm.2410015

BibTeX
@article{Khafagy2025,
  author = {Khafagy, El-Sayed and Soliman, Gamal A and Abdel-Kader, Maged S and Bendary, Mahmoud M and Hegazy, Wael A H and Askoura, Momen},
  title = {Enoxacin adversely affects Salmonella enterica virulence and host pathogenesis through interference with type III secretion system type II (T3SS-II) and disruption of translocation of Salmonella Pathogenicity Island-2 (SPI2) effectors},
  journal = {Journal of Microbiology},
  year = {2025},
  doi = {10.71150/jm.2410015}
}
Kostenlos starten →